26choiceM

Dow Jones vs. S&P 500: What UnitedHealth’s volatility reveals for investors

Key points:

  • UnitedHealth volatility highlights a key difference between the Dow and the S&P 500. UnitedHealth’s sharp decline and subsequent rebound had an outsized impact on the Dow, while the S&P 500 remained relatively unaffected, underscoring how index structure drives performance sensitivity.
  • The Dow is price-weighted; the S&P 500 is market-cap weighted. In the Dow, high-priced stocks like UNH can disproportionately move the index, even when most other components are flat or rising. In contrast, the S&P 500 spreads influence across a broader base, muting the effect of individual stock swings.
  • For long-term investors, the S&P 500 offers diversified, growth-oriented exposure while Dow offers a defensive tilt. The Dow’s construction makes it more sensitive to moves in a few names but also gives it a tilt toward value and defensive sectors—making it useful as a tactical complement in more volatile or late-cycle environments.


Note: This content is marketing material.

 

Last week, UnitedHealth Group (UNH) took center stage in U.S. equity markets—not for its gains, but for a sharp selloff that sent the stock nearly 23% lower. The move weighed heavily on the Dow Jones Industrial Average, where UNH holds significant influence due to the index’s price-weighted methodology.

The episode serves as a timely reminder of the structural differences between the Dow Jones and the S&P 500—and why understanding those differences is critical for investors making allocation decisions.

Why did UnitedHealth fall?

The stock declined sharply amid a convergence of negative developments:

  • Reports emerged that the U.S. Department of Justice had launched a criminal investigation into UnitedHealth’s Medicare Advantage billing practices.
  • The company withdrew its 2025 financial guidance, citing rising medical costs, particularly from newer Medicare Advantage patients.
  • The abrupt resignation of CEO Andrew Witty added to investor concerns and led to a broader selloff.

The stock ended the week down 23%, with most of the damage occurring on 13 May, when UNH fell 18% in a single day. You can read more about the great UnitedHealth collapse in this article: How a healthcare titan lost 54% in weeks

Why index construction matters

UnitedHealth is a constituent of both the Dow Jones Industrial Average and the S&P 500, but the way these indices are constructed means the impact of UNH’s moves is felt very differently.

The Dow is price-weighted, meaning a stock’s influence is based on its share price. UNH is one of the highest-priced stocks in the index, so large moves in its share price can swing the Dow significantly. On 13 May, despite half the Dow’s components closing higher, the index still fell around 270 points—with UNH accounting for over 400 points of downward pressure, according to our estimates.

By contrast, the S&P 500 is market-cap weighted, which spreads exposure more broadly across sectors and companies. While UNH’s sharp drop was felt, the S&P 500 still managed to close up 0.7%, lifted by gains in large-cap tech names. Notably, more than half of the index’s components ended the day in the red—underscoring how market-cap weighting can mute the impact of single-stock declines.

This dynamic played out in reverse just days later. On 19 May, UNH rebounded strongly—rising 8.2% in a single session. The Dow, with its heavy price-based exposure to UNH, gained 0.3%. The S&P 500, however, rose only 0.09%, again illustrating how index structure influences performance.


Index construction at a glance

Dow Jones Industrial Average

  • Composed of 30 large-cap U.S. companies.
  • Price-weighted: higher-priced stocks carry more index weight.
  • Tilts toward healthcare, industrials, and financials.
  • Highly sensitive to single-stock moves, as demonstrated by UNH’s drag.

S&P 500

  • Composed of 500 large-cap U.S. companies.
  • Market-cap weighted: larger companies by value have more influence.
  • Heavily weighted in tech and growth sectors.
  • Better represents broad market sentiment and reduces concentration risk.

Strategic implications for investors

Impact of individual stocks:

  • Due to the DJIA's price-weighted structure, high-priced stocks like UNH can disproportionately influence the index's performance.
  • The S&P 500's market-cap weighting dilutes the impact of any single stock, offering more diversified exposure.

Sector rotation considerations:

  • If there's a market rotation from technology to sectors like healthcare, the DJIA may benefit more due to its sector composition.
  • Investors anticipating such rotations might consider increasing exposure to the DJIA or sector-specific ETFs.
  • But in a tech-led rally, the S&P 500 is likely to lead.

Diversification and stability:

  • The S&P 500's broader base provides more stability and is less susceptible to volatility from individual stock movements.
  • For long-term investors seeking diversified exposure, the S&P 500 remains a foundational choice.
  • Holding both indices, or using ETFs that balance between value and growth sectors, may help navigate volatility and sector rotations more effectively.

Portfolio allocation considerations

Short-term tactical moves:

Investors looking to capitalize on potential rebounds in specific sectors, like healthcare, might consider targeted investments in the DJIA or sector-specific ETFs.

Long-term stability:

Maintaining a core allocation to the S&P 500 ensures broad market exposure and mitigates risks associated with individual stock volatility.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.